Assignee
TEVOGEN BIO INC
US·3 granted patents·3 pending applications·5 citations·filing 2020–2023
Top patents by PatentIndex Score
6 records- 0187US11191827B1COVID-19 peptide specific T-cells and methods of treating and preventing COVID-19TEVOGEN BIO INC·Filed 2020·Granted Dec 7, 2021·5 cites·17 claims
- 0263US11207401B1COVID-19 peptide specific T-cells and methods of treating and preventing COVID-19TEVOGEN BIO INC·Filed 2021·Granted Dec 28, 2021·0 cites·11 claims
- 0362US11219684B1COVID-19 peptide specific T-cells and methods of treating and preventing COVID-19TEVOGEN BIO INC·Filed 2021·Granted Jan 11, 2022·0 cites·17 claims
- 0462US2023372398A1Virus specific t-cells and methods of treating and preventing viral infectionsTEVOGEN BIO INC·Filed 2023·Application pending·0 cites
- 0558US2022202865A1Virus specific t-cells and methods of treating and preventing viral infectionsTEVOGEN BIO INC·Filed 2022·Application pending·0 cites
- 0652US2024358753A1Methods for developing cd3+cd8+ cells against multiple viral epitopes for treatment of viral infections including variants evolving to escape previous immunityTEVOGEN BIO INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TEVOGEN BIO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →